4-(2-((4-morpholinophenyl)amino)pyrimidin-4-yl)-N-(4-(trifluoromethyl)phenyl)piperazine-1-carboxamide

ID: ALA4474522

PubChem CID: 155537141

Max Phase: Preclinical

Molecular Formula: C26H28F3N7O2

Molecular Weight: 527.55

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(Nc1ccc(C(F)(F)F)cc1)N1CCN(c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)CC1

Standard InChI:  InChI=1S/C26H28F3N7O2/c27-26(28,29)19-1-3-21(4-2-19)32-25(37)36-13-11-35(12-14-36)23-9-10-30-24(33-23)31-20-5-7-22(8-6-20)34-15-17-38-18-16-34/h1-10H,11-18H2,(H,32,37)(H,30,31,33)

Standard InChI Key:  BOUSFRWZRKLHPH-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 38 42  0  0  0  0  0  0  0  0999 V2000
   21.2373  -18.0442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2362  -18.8679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9483  -19.2768    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.6621  -18.8674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6593  -18.0406    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.9465  -17.6312    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3746  -19.2749    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.3759  -20.0962    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6634  -20.5085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6643  -21.3290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3773  -21.7373    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0867  -21.3232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0823  -20.5040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3812  -22.5539    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.6687  -22.9675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6691  -23.7852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3803  -24.1956    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.0887  -23.7862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0899  -22.9622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9464  -16.8133    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.6589  -16.4038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6584  -15.5861    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9471  -15.1716    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.2347  -15.5852    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2335  -16.4092    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.9478  -14.3503    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6600  -13.9423    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.2363  -13.9411    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.3715  -14.3514    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3691  -15.1769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0756  -15.5901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7888  -15.1779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7868  -14.3523    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0755  -13.9469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5008  -15.5902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5013  -16.4115    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   26.2124  -15.1771    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   26.2079  -15.9971    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 14 15  1  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 11 14  1  0
 20 21  1  0
 20 25  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
  6 20  1  0
 23 26  1  0
 26 27  1  0
 26 28  2  0
 27 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 29  1  0
 32 35  1  0
 35 36  1  0
 35 37  1  0
 35 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4474522

    ---

Associated Targets(Human)

JAK2 Tclin Tyrosine-protein kinase JAK2 (12915 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT3 Tclin Tyrosine-protein kinase receptor FLT3 (13481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 527.55Molecular Weight (Monoisotopic): 527.2257AlogP: 4.43#Rotatable Bonds: 5
Polar Surface Area: 85.86Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.35CX Basic pKa: 5.70CX LogP: 4.62CX LogD: 4.61
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.51Np Likeness Score: -1.97

References

1. Li Y, Ye T, Xu L, Dong Y, Luo Y, Wang C, Han Y, Chen K, Qin M, Liu Y, Zhao Y..  (2019)  Discovery of 4-piperazinyl-2-aminopyrimidine derivatives as dual inhibitors of JAK2 and FLT3.,  181  [PMID:31408808] [10.1016/j.ejmech.2019.111590]

Source